S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|GE‘s Compression Technology Supporting Total S.A. to Expand and Enhance Its Antwerp Refinery|
|Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy|
|Roche receives EU approval for rheumatoid arthritis drug|
|FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer|
|Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf® (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening (2014/7/14)|
|FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer|
|Rogers Corporation Updates Guidance for the Second Quarter 2014 and Invites You to Join its Second Quarter 2014 Conference Call|
|Rogers Corporation Reports All-Time Record Quarterly Sales for the Second Quarter of 2014|
|Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo|
|Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of InterMune, Inc. Stockholders|
Click above to view more mutual fund data and stats for rog - Roche Holding AG Dividend Right Cert..